UCL Institute of Neurology
- IoN HOME
- About the Institute
- Study Here
- Research Departments
- Department of Brain Repair & Rehabilitation
- Department of Clinical and Experimental Epilepsy
- Department of Clinical Neuroscience
- Department of Molecular Neuroscience
- Department of Neurodegenerative Disease
- Department of Neuroinflammation
- Department Home
- Vacancies
- News
- Sources of support
- Publications
- Research themes
- Cell Signalling Laboratory
- Diagnosis, prognosis and therapeutic monitoring in MS
- Experimental neuroinflammation
- Magnetic resonance physics
- Mechanisms of disability and recovery in MS
- MRI & pathology in MS
- MS Clinical Trial Unit
- Neuroimmunology Unit
- Neuropsychiatry Group: Brain abnormalities in psychosis
- NeuroResource Tissue Bank
- NMR Research Unit
- Sobell Department of Motor Neuroscience and Movement Disorders
- Wellcome Department of Imaging Neuroscience
- Services & Library
- Vacancies and PhD Projects
- Contact Us
- National Hospital for Neurology and Neurosurgery
- Support Us
- IoN Intranet
- Department Home
- Vacancies
- News
- Sources of support
- Publications
-
Research themes
- Cell Signalling Laboratory
- Diagnosis, prognosis and therapeutic monitoring in MS
- Experimental neuroinflammation
- Magnetic resonance physics
- Mechanisms of disability and recovery in MS
- MRI & pathology in MS
- MS Clinical Trial Unit
- Neuroimmunology Unit
- Neuropsychiatry Group: Brain abnormalities in psychosis
- NeuroResource Tissue Bank
- NMR Research Unit
MS Clinical Trial Unit
Dr Gavin Giovannoni
In partnership with the NHNN, this Unit is responsible for the performing clinical trials in subjects with MS.
Currently, several phase II and phase III studies are evaluating a spectrum of novel disease modifying therapies for MS (e.g. natalizumab, an anti-adhesion molecule therapy). In partnership with the NMR Research Unit, the MS Clinical Trials Unit is now in a position to assist and perform investigator-led studies; this important function helps in the translation of other MS-related basic research currently been undertaken at the ION.
